Industry news, page-2

Super interesting read mate, its screams out exactly how EMD are going to expedite any TGA and FDA assessments I feel thanks to our huge (RWE) data bases EMD will become a takeover target for some big cashed up Pharma at some point very soon, enter Karen Smith

Enter RWD to fill critical evidence gaps. Increasingly, information from electronic health records, claims data, patient registries, inpatient or outpatient data, scientific literature and even patient surveys are being accepted by both regulatory and health technology assessment agencies as valuable sources of RWD to supplement clinical trial findings.